Disruptive mood dysregulation disorder: does variance in treatment responses also add to the conundrum? The widening gap in the evidence is a signal needing attention

CNS Spectr. 2022 Dec;27(6):659-661. doi: 10.1017/S1092852921000985. Epub 2021 Nov 18.

Abstract

The new diagnosis of disruptive mood dysregulation disorder (DMDD) was introduced in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition, to address the overdiagnosis of bipolar disorder in children and adolescents. However, there are ongoing debates about its nosology given chronic persistent irritability in children and adolescents has contextual valence. Those meeting the criteria for DMDD may, in fact, have an oppositional defiant disorder, attention deficit hyperactivity disorder, or other behavioral disorders. Similarly, in the last few years, there are many different types of treatment studies that have also yielded mixed results. These counterintuitive findings need a meticulous review for a wider debate given its clinical utility for patients, families, and practicing clinicians.

Keywords: attention deficit hyperactivity disorder; bipolar disorder; children and adolescents; diagnosis; disruptive mood dysregulation disorder.

Publication types

  • Editorial

MeSH terms

  • Adolescent
  • Attention Deficit and Disruptive Behavior Disorders* / diagnosis
  • Attention Deficit and Disruptive Behavior Disorders* / therapy
  • Bipolar Disorder* / diagnosis
  • Bipolar Disorder* / drug therapy
  • Child
  • Diagnostic and Statistical Manual of Mental Disorders
  • Humans
  • Irritable Mood
  • Mood Disorders / diagnosis